Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / App Notes / 2021 / Quantitative Analysis of Favipiravir Spiked in Plasma Using by HPLC

Quantitative Analysis of Favipiravir Spiked in Plasma Using by HPLC

03/02/2021

Share

Featured Image

As of 2020, the development of both pharmaceuticals and vaccines remains urgent to overcome the global coronavirus disease 2019 (COVID-19) pandemic. Favipiravir (brand name: Avigan®), a promising drug candidate for COVID-19, is classified as an antiinfluenza drug, evaluated and developed for both novel and re-emerging influenza viruses. (1), (2) Favipiravir undergoes renal excretion, eliminated in the urine mainly as a hydroxide. Notably, the plasma levels of this drug are difficult to control owing to its once daily dosing regimen. (3) Consequently, the accurate monitoring of drug levels is crucial.

In this report, we introduce a unique approach for the quantitative high sensitivity plasma analysis of favipiravir using only a standard high-pressure liquid chromatography (HPLC) setup without mass spectrometry.

HPLC Analysis

Favipiravir *1 was purchased from Alsachim. The calibration curve and quality control (QC) samples were prepared by spiking healthy human plasma with favipiravir. The measurement was performed using HPLC analytical conditions shown in Table 1. The time program of gradient elution is shown in Table 2. Favipiravir was separated using an HPLC instrument fitted with Shim-pack Scepter™ C18-120 with a guard column. The chromatograms are shown in Fig. 3. A calibration curve was generated using favipiravir standard solutions of at 1, 10, 25, 50, and 100 μg/mL (n = 6) spiked in plasma.

>> Download the Full Application Note as a PDF

Newsletters

Receive the latest analytical scientist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Analytical Science

Dive deeper into the analytical science. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Removing User Bias from Structure Verification by NMR
Removing User Bias from Structure Verification by NMR

November 15, 2021

Chemical structure verification by NMR is one of t...

Simultaneous Determination of Eight Nitrosamine Impurities in Metformin Extended-Release Tablets Using the Agilent 6470 Triple Quadrupole LC/MS
Simultaneous Determination of Eight Nitrosamine Impurities in Metformin Extended-Release Tablets Using the Agilent 6470 Triple Quadrupole LC/MS

November 15, 2021

Detection of regulated genotoxic impurities from t...

HIGH RESOLUTION MULTI-REFLECTING TIME-OF-FLIGHT MASS ANALYZER WITH FOLDED FLIGHT PATH®
HIGH RESOLUTION MULTI-REFLECTING TIME-OF-FLIGHT MASS ANALYZER WITH FOLDED FLIGHT PATH®

November 15, 2021

How high does resolving power need to be?

Biomarker discovery
Biomarker discovery

November 16, 2021

Essential guide to analysing VOCs in breath and other biological samples...

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.